Sign in

Thomas Kislinger

@kislingerthomas.bsky.social
360 followers 195 following 36 posts

Senior Scientist at Princess Margaret Cancer Centre, Toronto, Canada 🇨🇦 Clinical proteomics, liquid biopsies and cell surface markers

PostsRepliesMedia
Reposted by Thomas Kislinger
Cell Reports Medicine @cp-cellrepmed.bsky.social · 29/01/2026
Online now: Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as an actionable surface target
dlvr.it
Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as an actionable surface target
Govindarajan et al. leverage N-glycoproteomics and PDX models to decode the in vivo cancer cell surfaceome and establish Glyco PDXplorer—a target discovery platform. The identification and validation of FAT2 as a previously undescribed, actionable antigen demonstrates the utility of Glyco PDXplorer for uncovering therapeutic vulnerabilities.
021
Thomas Kislinger @kislingerthomas.bsky.social · 23/01/2026
Raising a novel antibody, we demonstrate that FAT2 expression is associated with patient outcome. Reformatting to a CAR-T demonstrated anti-tumor activity in pre-clinical models.
010
Thomas Kislinger @kislingerthomas.bsky.social · 23/01/2026
We develop a PDX-based N-glycoproteomics strategy to discover cancer-enriched cell surface targets and identify FAT2 as a novel, largely unexplored squamous cell marker that is essential for cellular growth and survival.
100
Thomas Kislinger @kislingerthomas.bsky.social · 23/01/2026
Checkout our new paper published in @cp-cellrepmed.bsky.social www.cell.com/cell-reports... Fantastic work by Meinusha Govindarajan and Salvador Mejia-Guerrero with lots of help from our many collaborators and colleagues. #glycotime
121
Reposted by Thomas Kislinger
Rebekah Gundry @gundrylab.bsky.social · 23/10/2025
Interested in surface proteomics for drug discovery?? Come to our @hupo-org.bsky.social Workshop on Sunday, Nov 9 at HUPO in Toronto! Excited to host with Amanda Lorentzain and learn from @berndwollscheid.bsky.social, Susan Klaeger and Thomas Kislinger!
061
Reposted by Thomas Kislinger
CNPN @cnpn-org.bsky.social · 17/10/2025
CNPN2025 will be held on November 8th to kick off HUPO2025! We have the honor to introduce our keynote speaker and fantastic invited speaker 🥳 @kislingerthomas.bsky.social and @philipplange.bsky.social For more info about the program: cnpn.ca/cnpn2025/ #precisionmedicine #biomarkerdiscovery
142
Thomas Kislinger @kislingerthomas.bsky.social · 07/09/2025
And in case you missed it, here is her second, equally impressive second preprint. www.biorxiv.org/content/10.1...
biorxiv.org
Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as a therapeutic target for head and neck cancers
Cell surface proteins offer significant cancer therapeutic potential attributable to their accessible membrane localization and central role in cellular signaling. Despite this, their promise remains ...
000
Thomas Kislinger @kislingerthomas.bsky.social · 07/09/2025
Latest preprint from the lab. Great work as always by Meinusha. This is the last chapter for her PhD. www.biorxiv.org/content/10.1...
biorxiv.org
Surface proteomics reveals arginine metabolism as a vulnerability in high grade serous ovarian cancer
The significant lethality of high-grade serous ovarian cancer (HGSC) is driven by the lack of long- term efficacy of current treatments, underscoring the need for developing additional therapeutics. C...
120
Thomas Kislinger @kislingerthomas.bsky.social · 04/09/2025
pubmed.ncbi.nlm.nih.gov/40894632/
pubmed.ncbi.nlm.nih.gov
Ancestry-Dependent Immunologic and Prognostic Effects Characterize the Prostate Cancer Urinary Proteome - PubMed
Urine is an attractive biomarker analyte for non-invasive longitudinal monitoring of health and disease, particularly for diseases of the genitourinary tract, like prostate and bladder cancer. The com...
000
Thomas Kislinger @kislingerthomas.bsky.social · 20/08/2025
Interestingly, the urinary proteome of Black patients harboured more features of aggressive cancers than those of grade- and PSA-matched White patients. These observations highlight the importance of controlling for ancestry-associated differences in biomarker development.
000
Thomas Kislinger @kislingerthomas.bsky.social · 20/08/2025
This cohort was stratified by ancestry – thought to be a risk-factor for aggressive disease. We found surprisingly large differences and dysregulation of immune pathways.
100
Thomas Kislinger @kislingerthomas.bsky.social · 20/08/2025
After nearly 15 years of urine proteomics of prostate cancer patients, this is our most comprehensive work to date. We generated spectral libraries from hundreds of samples to rapidly analyze 329 post-DRE urines.
100
Thomas Kislinger @kislingerthomas.bsky.social · 20/08/2025
Checkout our latest pre-print www.biorxiv.org/content/10.1...
biorxiv.org
Ancestry-Dependent Immunologic and Prognostic Effects Characterize the Prostate Cancer Urinary Proteome
Urine is an attractive biomarker analyte for non-invasive longitudinal monitoring of health and disease, particularly for diseases of the genitourinary tract, like prostate and bladder cancer. The com...
100
Thomas Kislinger @kislingerthomas.bsky.social · 01/07/2025
Phenotypic screens for SIRPA expression reveal RAB21 as a general regulator of macrophage surface identity: Cell Reports www.cell.com/cell-reports...
cell.com
Phenotypic screens for SIRPA expression reveal RAB21 as a general regulator of macrophage surface identity
Through CRISPR screening, Granda Farias et al. find results consistent with cis CD47-SIRPA interactions relying on QPCTL and that RAB21/Rab21 inactivation reduces macrophage model surface SIRPA/Sirpa ...
020
Thomas Kislinger @kislingerthomas.bsky.social · 16/06/2025
‪checkout our latest paper in @natbiotech.nature.com . We developed a graph-based algorithm that comprehensively generates non-canonical peptides in linear time. www.nature.com/articles/s41...
nature.com
Identification of non-canonical peptides with moPepGen - Nature Biotechnology
moPepGen enables the detection of peptides across species, proteases and technologies.
0151
Reposted by Thomas Kislinger
Nature Biotechnology @natbiotech.nature.com · 16/06/2025
Identification of non-canonical peptides with moPepGen - @uclahealth.org @uoftmedicine.bsky.social @kislingerthomas.bsky.social go.nature.com/3HYJyyz
go.nature.com
Identification of non-canonical peptides with moPepGen - Nature Biotechnology
moPepGen enables the detection of peptides across species, proteases and technologies.
2155
Thomas Kislinger @kislingerthomas.bsky.social · 05/05/2025
New collaborative work from PhD student Aastha. Using proteomics for CSF-based biomarker discovery pubmed.ncbi.nlm.nih.gov/40321620/
pubmed.ncbi.nlm.nih.gov
Cerebrospinal fluid protein biomarkers are associated with response to multiagent intraventricular chemotherapy in patients with CNS lymphoma - PubMed
The study identified CSF-based proteomic biomarkers, particularly LCP1, that can classify MAIVC response and indicate tumor burden in CNSL patients.
000
Thomas Kislinger @kislingerthomas.bsky.social · 01/05/2025
academic.oup.com/noa/advance-...
academic.oup.com
CSF protein biomarkers are associated with response to multi-agent intraventricular chemotherapy in patients with CNS lymphoma
AbstractBackground. Central nervous system lymphoma (CNSL), is a rare subtype of non-Hodgkin lymphoma, primarily affecting the brain and spinal cord. Most
000
Thomas Kislinger @kislingerthomas.bsky.social · 14/04/2025
New review from our team. pubmed.ncbi.nlm.nih.gov/40227112/
pubmed.ncbi.nlm.nih.gov
Recent implementations of data-independent acquisition for cancer biomarker discovery in biological fluids - PubMed
Various studies showed the potential of DIA-MS in identifying putative cancer biomarkers in a high-throughput manner. However, the lack of proper study design and standardization of methods across pla...
010
Thomas Kislinger @kislingerthomas.bsky.social · 11/03/2025
I am everywhere and nowhere 👻
010
Thomas Kislinger @kislingerthomas.bsky.social · 30/12/2024
www.nature.com/articles/s41...
nature.com
Molecular correlates for HPV-negative head and neck cancer engraftment prognosticate patient outcomes - Nature Communications
‘Engraftment of patient-derived xenografts in samples from head and neck squamous cell carcinoma is variable. Here, the authors use transcriptomic and proteomic profiling to correlate engraftment of P...
052
Thomas Kislinger @kislingerthomas.bsky.social · 30/12/2024
Last paper for 2024. Nice work by PDF Matt Waas on proteomics of HNSCC tissues to identify novel biomarkers within the N0 population. Great collaboration with Laurie Ailles and support from many colleagues Princess Margaret Cancer Centre
150
Thomas Kislinger @kislingerthomas.bsky.social · 15/12/2024
Definitely also expressed in skin.
000
Thomas Kislinger @kislingerthomas.bsky.social · 15/12/2024
It gets upregulated in squamous carcinomas and is required for growth and survival
120
Thomas Kislinger @kislingerthomas.bsky.social · 15/12/2024
There is expression in the cerebellum for sure. Might be through that route Not sure how it gets into milk. Maybe low level expression in some mammary epithelial populations. I will look at our own CSF, urine and normal mammary populations tomorrow.
010
Thomas Kislinger @kislingerthomas.bsky.social · 15/12/2024
Actually most datasets correlate reasonable well for Fat2. Since I have worked on this protein for the last 8 years
100
Thomas Kislinger @kislingerthomas.bsky.social · 15/12/2024
Let us know your thoughts
000
Reposted by Thomas Kislinger
bioRxivpreprint @biorxivpreprint.bsky.social · 14/12/2024
Pan-cancer N-glycoproteomic atlas of patient derived xenografts uncovers FAT2 as a therapeutic target for head and neck cancers www.biorxiv.org/content/10.1101/202…
011
Reposted by Thomas Kislinger
bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 14/12/2024
Pan-cancer N-glycoproteomic atlas of patient derived xenografts uncovers FAT2 as a therapeutic target for head and neck cancers www.biorxiv.org/content/10.1101/202…
032
Thomas Kislinger @kislingerthomas.bsky.social · 14/12/2024
As mentioned a large number of colleagues contributed to this work, most importantly the project was led by a fantastic PhD student Meinusha Govindarajan and a research associate Salvador Mejia-Guerrero.
020
Thomas Kislinger @kislingerthomas.bsky.social · 14/12/2024
The entire data will be evaluable as a searchable web-interface (Glyco PDXplorer).
110
Thomas Kislinger @kislingerthomas.bsky.social · 14/12/2024
Fat2 deletion leads to regulation of surface architecture and integrin-PI3K signaling. Finally we raise a highly specific Fat2 antibody which we repurposed into a CAR T construct for proof-of-concept preclinical evaluation.
110
Thomas Kislinger @kislingerthomas.bsky.social · 14/12/2024
We discover Fat2 as a novel head and neck cancer surface antigen that has minimal expression in normal human tissues, is essential for tumour grown in vitro and in vivo and high expression is associated with poor survival
110
Thomas Kislinger @kislingerthomas.bsky.social · 14/12/2024
We developed a discovery pipeline that utilizes N-glycoproteomics in PDX models to discover novel cancer specific surface antigenes. We initially focus on head and neck cancers and combine our data with patient tumours and cell surface capture
131
Thomas Kislinger @kislingerthomas.bsky.social · 14/12/2024
Big effort (> 7 years) from a large number of colleagues. Finally on BioRxiv and to be submitted in January Pan-cancer N-glycoproteomic atlas of patient derived xenografts uncovers FAT2 as a therapeutic target for head and neck cancers www.biorxiv.org/content/10.1...
biorxiv.org
Pan-cancer N-glycoproteomic atlas of patient derived xenografts uncovers FAT2 as a therapeutic target for head and neck cancers
Cell surface proteins offer significant cancer therapeutic potential attributable to their accessible membrane localization and central role in cellular signaling. Despite this, their promise remains ...
2172
Thomas Kislinger @kislingerthomas.bsky.social · 13/12/2024
Very nice!
000
Thomas Kislinger @kislingerthomas.bsky.social · 08/12/2024
Boomerang bowl completed
160
Thomas Kislinger @kislingerthomas.bsky.social · 08/12/2024
A day of skiing at Lake Louise
1111
Thomas Kislinger @kislingerthomas.bsky.social · 06/12/2024
Great talk by Meinusha winning a Lake Louise travel award #lakelouise2024
081
Thomas Kislinger @kislingerthomas.bsky.social · 05/12/2024
Back at the Lake Louise Tandem Mass Spec conference
180
Thomas Kislinger @kislingerthomas.bsky.social · 02/12/2024
Ideal screening process!
020
Thomas Kislinger @kislingerthomas.bsky.social · 23/11/2024
www.nature.com/articles/s41...
nature.com
Prostate cancer reshapes the secreted and extracellular vesicle urinary proteomes - Nature Communications
Urine can be used to easily analyse the health of patients. Here, the authors identify proteins in urinary extracellular vesicles that distinguish prostate cancer from benign lesions.
080